Thomas B. Smith, Chief Medical Officer at BIODELIVERY SCIENCES INTERNATIONAL INC (BDSI), sold 2,927 shares at $5.38 ($16K) on 2020-01-31, disclosed to the SEC on 2020-02-04.
Scheduled sale ($16k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| COLL | SELL | 2024-03-04 | $37K | — | Filing → |